- Home
- MNPR vs SIFY Comparison
MNPR vs SIFY Comparison
Compare MNPR & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- SIFY
- Stock Information
- Founded
- MNPR 2014
- SIFY 1995
- Country
- MNPR United States
- SIFY India
- Employees
- MNPR N/A
- SIFY N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- SIFY Computer Software: Programming Data Processing
- Sector
- MNPR Health Care
- SIFY Technology
- Exchange
- MNPR Nasdaq
- SIFY Nasdaq
- Market Cap
- MNPR 244.1M
- SIFY 218.1M
- IPO Year
- MNPR 2019
- SIFY 1999
- Fundamental
- Price
- MNPR $40.33
- SIFY $4.39
- Analyst Decision
- MNPR Strong Buy
- SIFY
- Analyst Count
- MNPR 5
- SIFY 0
- Target Price
- MNPR $49.60
- SIFY N/A
- AVG Volume (30 Days)
- MNPR 30.6K
- SIFY 53.4K
- Earning Date
- MNPR 05-08-2025
- SIFY 04-21-2025
- Dividend Yield
- MNPR N/A
- SIFY N/A
- EPS Growth
- MNPR N/A
- SIFY N/A
- EPS
- MNPR N/A
- SIFY N/A
- Revenue
- MNPR N/A
- SIFY $465,333,571.00
- Revenue This Year
- MNPR $34.06
- SIFY N/A
- Revenue Next Year
- MNPR N/A
- SIFY $13.44
- P/E Ratio
- MNPR N/A
- SIFY N/A
- Revenue Growth
- MNPR N/A
- SIFY 14.34
- 52 Week Low
- MNPR $1.72
- SIFY $1.80
- 52 Week High
- MNPR $54.30
- SIFY $10.14
- Technical
- Relative Strength Index (RSI)
- MNPR 56.65
- SIFY 48.15
- Support Level
- MNPR $36.80
- SIFY $4.26
- Resistance Level
- MNPR $43.00
- SIFY $4.60
- Average True Range (ATR)
- MNPR 5.32
- SIFY 0.31
- MACD
- MNPR 0.94
- SIFY -0.06
- Stochastic Oscillator
- MNPR 63.41
- SIFY 18.31
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.